Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page
- Check4 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.0%
- Check39 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.SummaryDifference1%
- Check54 days agoChange DetectedSeveral key URLs related to genetics, breast cancer, and clinical trials have been removed, indicating a significant reduction in available resources on these topics.SummaryDifference2%
- Check61 days agoChange DetectedThe website has been updated to version 2.12.2, with new resources added including links to MedlinePlus and DailyMed for breast cancer treatments and clinical trial documents.SummaryDifference2%
- Check76 days agoChange DetectedThe website has been updated from version v2.11.2 to v2.12.1.SummaryDifference0.1%
Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.